Pharmacokinetics of verapamil from an osmotic system with delayed onset

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 42, Issue 1, 1996, Pages 74-81

  Gupta, S K ^a   Atkinson, L ^a   Theeuwes, F ^a   Wong, P ^a   Gilbert, P J ^a   Longstreth, J ^a  

^a ALZA CORPORATION   (United States)

Author keywords

Absorption; Delayed release; In vitro and in vivo correlation; Norverapamil; Pharmacokinetics; Verapamil

Indexed keywords

VERAPAMIL;

ADULT; ARTICLE; BIOAVAILABILITY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG FORMULATION; DRUG RELEASE; ENANTIOMER; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; RANDOMIZED CONTROLLED TRIAL;

EID: 0030012167     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)